仙琚制药：公司注射用维库溴铵拟中选第十一批全国药品集中采购

Core Viewpoint - The company participated in the 11th national centralized procurement organized by the National Organization for Drug Procurement from October 27 to October 28, 2025, with its product, injection vecuronium bromide, expected to be selected in this procurement [1] Financial Performance - The sales revenue of injection vecuronium bromide for the year 2024 is projected to be 17.6915 million yuan, accounting for 0.44% of the company's total revenue for 2024 [1] - For the period from January to September 2025, the sales revenue reached 14.1840 million yuan, representing 0.50% of the company's total revenue for the same period [1]